Previous Article | Next Article 
Journal of Virology, May 1999, p. 4266-4271, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Genetic and Phenotypic Changes Accompanying the
Emergence of Epizootic Subtype IC Venezuelan Equine Encephalitis
Viruses from an Enzootic Subtype ID Progenitor
Eryu
Wang,1
Roberto
Barrera,2
Jorge
Boshell,3
Cristina
Ferro,3
Jerome E.
Freier,4
Juan Carlos
Navarro,2
Rosalba
Salas,5
Clovis
Vasquez,5 and
Scott C.
Weaver1,*
Center for Tropical Diseases and Department
of Pathology, University of Texas Medical Branch, Galveston, Texas
77555-06091; Instituto de Zoologia
Tropical, Universidad Central de Venezuela,2 and
Instituto Nacional de Higiene,5
Caracas, Venezuela; Instituto Nacional de Salud, Bogota,
Colombia3; and USDA Center for Animal
Disease Information and Analysis, Fort Collins, Colorado
805214
Received 29 October 1998/Accepted 26 January 1999
 |
ABSTRACT |
Recent studies have indicated that epizootic Venezuelan equine
encephalitis (VEE) viruses can evolve from enzootic, subtype ID strains
that circulate continuously in lowland tropical forests (A. M. Powers, M. S. Oberste, A. C. Brault, R. Rico-Hesse, S. M. Schmura, J. F. Smith, W. Kang, W. P. Sweeney, and S. C. Weaver, J. Virol. 71:6697-6705, 1997). To identify mutations
associated with the phenotypic changes leading to epizootics, we
sequenced the entire genomes of two subtype IC epizootic VEE virus
strains isolated during a 1992-1993 Venezuelan outbreak and four
sympatric, subtype ID enzootic strains closely related to the predicted
epizootic progenitor. Analysis by maximum-parsimony phylogenetic
methods revealed 25 nucleotide differences which were predicted to have accompanied the 1992 epizootic emergence; 7 of these encoded amino acid
changes in the nsP1, nsP3, capsid, and E2 envelope glycoprotein, and 2 were mutations in the 3' untranslated genome region. Comparisons with
the genomic sequences of IAB and other IC epizootic VEE virus strains
revealed that only one of the seven amino acid changes associated with
the 1992 emergence, a threonine-to-methionine change at position 360 of
the nsP3 protein, accompanied another VEE virus emergence event. Two
changes in the E2 envelope glycoprotein region believed to include the
major antigenic determinants, both involving replacement of uncharged
residues with arginine, are also candidates for epizootic determinants.
 |
INTRODUCTION |
Venezuelan equine encephalitis (VEE)
virus is a member of the Alphavirus genus of the family
Togaviridae, a group of enveloped, single-stranded,
positive-sense RNA viruses (9, 29). The VEE virus genome is
about 11.4 kb; the 5' two-thirds encodes four nonstructural proteins
(nsP1 through 4) required for replication of the RNA genome, and the 3'
one-third encodes the structural proteins (capsid and envelope
glycoproteins E2 and E1). The genomic RNA is capped at the
5' terminus with 7-methylguanosine and is polyadenylated at the 3'
terminus. The nonstructural proteins are translated from genomic RNA as
one or two polyproteins (nsP1-3 or nsP1-4) and proteolytically
cleaved to produce nsP1, nsP2, nsP3, and nsP4, as well as partially
cleaved polyproteins. The structural proteins are processed
from a polyprotein translated from a 26S subgenomic mRNA that
is identical in sequence to the 3'-terminal one-third of the genomic
RNA. The alphavirus virion contains an icosahedral nucleocapsid that
consists of 240 copies of the capsid protein, surrounded by a lipid
envelope which is derived from the plasma membrane of infected cells,
in which glycoprotein E1 and E2 heterodimers are embedded
(28, 29).
The VEE antigenic complex is one of three major alphavirus serogroups
found in the New World and is comprised of six antigenic subtypes
(33). The viruses of subtypes II through VI, as well as
subtype I, varieties D to F, are not associated with major epidemics or
equine epizootics and are therefore referred to as enzootic strains. In
contrast, viruses belonging to subtypes IAB and IC have been isolated
only during epizootic and epidemic VEE outbreaks involving up to
hundreds of thousands of equines and people, with high rates of
morbidity and mortality (33, 34, 38). VEE epidemics and
epizootics have occurred sporadically in the Americas since the virus
was first isolated in 1938 (1, 14). No outbreaks were
reported between 1973 and 1992, prompting speculation that
epidemic/epizootic serotypes IAB and IC had become extinct
(33). However, after 19 years of absence, equine epizootics caused by subtype IC viruses recurred in Venezuela in 1992 (22) and in Venezuela and Colombia again in 1995 (38).
Phylogenetic studies of all VEE virus serotypes by limited genome
sequencing indicate that epizootic subtype IAB and IC viruses have
evolved independently at least three times from enzootic, equine-avirulent subtype ID-like strains that circulate continuously in
lowland tropical forest habitats of northern South America (21,
37). Comparison of the genomic sequence of an IC strain isolated
in a 1963 Venezuelan epidemic (P676) to that of an enzootic ID virus
from Panama (3880) showed nucleotide differences yielding only 66 amino
acid differences (13), also suggesting that ID strains may
be progenitors of epizootic strains.
Partial genomic sequencing of two epizootic IC isolates (243937 and SH3) isolated during a 1992-1993 Venezuelan outbreak
revealed that they are extremely closely related to two ID isolates
(66637 and 66457) from Sinamaica, in northwestern Venezuela near the Guajira Peninsula. These viruses differ by only 11 of 817 nucleotides (1.3%) in partial PE2 sequences (21). This similarity and
the deduced phylogenetic relationships provide strong evidence that the
1992-1993 outbreak originated from local enzootic ID viruses that
mutated to become subtype IC. Because serotype ID viruses are believed
to be avirulent for equines and do not generate sufficient viremia for
epizootic transmission (32, 33), this phenotypic transition presumably included the acquisition of equine virulence. To
identify the mutations responsible for these phenotypic changes, we
sequenced the complete genomes of two subtype IC epizootic strains from the 1992-1993 Venezuelan outbreak and four closely related, sympatric, subtype ID enzootic isolates. Sequence comparisons and phylogenetic analyses indicated that one or more of seven amino
acid changes in nsP1, nsP3, the capsid, and E2 may be responsible for
epizootic emergence. Plaque size phenotypes of the IC isolates were distinct from those of the ID isolates, consistent with previous studies showing a difference between epizootic and enzootic phenotypes.
 |
MATERIALS AND METHODS |
Virus preparation, PCR amplification, and sequencing.
Six
VEE virus strains were sequenced in this study. Two subtype IC
epizootic strains (243937 and SH3) were isolated during an
equine epizootic and epidemic that occurred in western
Venezuela during 1992 and 1993 (22). Four ID enzootic
strains (66637, 66457, 83U434, and ZPC738) were isolated from sentinel
hamsters exposed to the virus in tropical lowland forests of western
Venezuela or eastern Colombia at various times between 1981 and 1997 (5, 31) (Table 1). Strain
ZPC738, isolated in 1997, was characterized antigenically as subtype ID
with monoclonal antibodies in an immunofluorescence assay as described
previously (23). Virus stocks were prepared on BHK cell
monolayers at 37°C with a multiplicity of infection of 0.1 to 1.0 PFU
per cell. After cytopathic effects were evident, RNA was extracted by
using Trizol LS (Bethesda Research Laboratories, Bethesda, Md.)
according to the manufacturer's protocol, and reverse transcription-PCR was performed as described previously (2). Six pairs of oligonucleotide primers (Table
2) were designed to produce overlapping
amplicons covering the entire VEE virus genome. First-strand cDNAs were
synthesized with the antisense primers Mlu-25V, which primes synthesis
at the 3' poly(A) tail of the genomic RNA, and 5251(
). PCR products
were cloned into the pCR2.1 vector (Invitrogen, San Diego, Calif.), and
bacterial colonies were screened by restriction enzyme digestion. The
cDNA of the 5' terminus of the genome was obtained with antisense
primer V-1245(
) and was tailed with dCTP acid at its 3' terminus by using the 5' rapid amplification of cDNA ends system (Bethesda Research
Laboratories). PCR products and clones were sequenced with an Applied
Biosystems (Foster City, Calif.) Prism automated DNA sequencing kit and
sequencer according to the manufacturer's protocol. Additional primers
were synthesized for sequencing, and their sequences are available upon
request. For each virus strain, two or more clones were sequenced to
confirm the nucleotide differences found among virus strains.
Discrepancies were resolved by sequencing PCR amplicons directly to
identify the consensus nucleotides.
Phylogenetic analyses.
Nucleotide and deduced amino acid
sequences were aligned by using the PILEUP program of the Genetics
Computer Group (4). Phylogenetic analyses of the aligned
sequences were performed with the PAUP maximum-parsimony program
(30) to predict the ancestral sequences of viral
progenitors. Confidence values were obtained by bootstrapping
(6).
Plaque assays.
Plaque assays were performed on Vero cell
monolayers as described previously (16). Each virus sample
was diluted and added to six-well cell culture plates and incubated for
45 min at 34°C. Monolayers were then overlaid with 4 ml of Eagle's
minimal essential medium supplemented with 1% agar and 2% fetal
bovine serum. After 46 to 48 h of incubation at 37°C, 2 ml of a
second overlay containing 0.008% neutral red was added. Eighteen hours
after the second overlay, the plates were examined, and the wells
containing between 10 and 50 distinct plaques were selected for
measuring plaque diameters. A total of 30 plaques was measured for each
strain. For irregularly shaped plaques, two measurements were made at right angles to each other and averaged.
Nucleotide sequence accession numbers.
Nucleotide sequences
were deposited in the GenBank library under accession no. AF004458,
AF004459, AF004472, and AF100566 and updates U55360 and U55362.
 |
RESULTS |
Nucleotide and amino acid sequences of ID and IC VEE viruses.
The RNA genome of each of the VEE subtype ID and IC viruses we
sequenced was 11,420 nucleotides in length, except for strain ZPC738,
which had an adenosine insertion after nucleotide position 42 in the 5'
untranslated region, and strain 83U434, which had a 21-nucleotide
insertion (seven codons) after position 5047 in its nsP3 gene
(numberings are for strain 66637, GenBank accession no. AF004458). This
insertion is also found in the Trinidad donkey (subtype IAB)
(12) and P676 (subtype IC) genomes (13), as well
as in the genome of strain 68U201 (subtype IE) (19), suggesting that an ancestor of the 66637, 66457, ZPC738, SH3, and
243937 strains underwent a 21-nucleotide deletion. A summary of the
variable nucleotide positions and deduced amino acids is shown in Table
3. Comparisons revealed a total of 219 variable nucleotides, with 41 amino acid differences (Fig.
1). The nucleotide differences were
scattered throughout the genomes of both ID and IC viruses. The
greatest nucleotide sequence variability was found in the 6K (3.0%),
E2 (2.7%), nsP3 (2.4%), E3 (2.3%), and nsP2 (2.2%) gene regions.
The E3 and nsP3 genes also showed the greatest amounts of amino acid
variation, at 3.4 and 2.0%, respectively. The ratio of transitions to
transversions was 4.13:1, nearly identical to previous estimates of
alphavirus substitutions (2, 36).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 1.
Summary of variable amino acids among 1992-1993
epizootic Venezuelan IC and sympatric enzootic ID viruses. Dots
indicate same amino acid as is present in strain 66637.
|
|
The nucleotide sequences of two of the enzootic subtype ID strains,
66637 and 66457, were nearly identical, with only 10 nucleotide
differences and no amino acid differences. Strain ZPC738 had 108
nucleotide differences from these two strains, with an additional
nucleotide insertion in the 5' untranslated region. Twenty amino
acid
differences were found between ZPC738 and the two 1981 ID
strains.
Comparison of another ID strain, 83U434, with 66637 and
66457 revealed
116 nucleotide differences, including an in-frame
21-nucleotide
insertion in nsP3, and a total of 27 amino acid
differences (Fig.
1).
Analysis of the genomic sequences of the two subtype IC strains,
243937 and SH3, indicated that they differed by only 15 nucleotides
and three amino acids: nsP3 position 463 (L
[243937] versus H
[SH3]), nsP4 position 2 (I [243937] versus T
[SH3]), and E1 position
384 (K [243837] versus R [SH3]).
Comparison of these IC sequences
with the ID sequences revealed 75 to
140 nucleotide differences
(0.7 to 1.2%) in pairwise comparisons
and 15 to 26 amino acid
differences (0.4 to 0.7%), with differences in
all of the viral
genes.
Relationships of ID and IC viruses.
To estimate the nucleotide
and amino acid changes that accompanied the emergence of the 1992 epizootic IC phenotype, phylogenetic analyses of genomic
nucleotide and complete polyprotein amino acid sequences were
conducted. Five other genomic sequences published previously were
included: the Trinidad donkey epizootic IAB strain isolated in
1943 and its TC-83 vaccine derivative (12), the epizootic IC strain P676 isolated in 1963 in Venezuela
(13), the enzootic ID strain 3880 isolated in 1961 in Panama
(13), and the enzootic IE strain 68U201 isolated in 1968 in
Guatemala (19). Maximum-parsimony analyses revealed that the
Venezuelan and Colombian ID viruses group closely with
epizootic/epidemic IC and IAB viruses (Fig.
2), in agreement with the results of previous studies employing shorter sequences (21, 37). When the epidemiological phenotype of each strain (enzootic ID or IE versus
epizootic IAB or IC) was used as a character and its change minimized in the internal tree branches, the independent evolution of
three epizootic lineages from enzootic progenitors was
predicted (Fig. 2). Examination for the amino acid changes predicted to have accompanied these three emergence events revealed 7 for the 1992 IC emergence, 23 for the subtype IAB emergence, and 24 for the 1963 subtype IC emergence (Fig. 2). The seven changes predicted to have
accompanied the 1992 emergence included two amino acid changes in nsP1,
two in nsP3, one in the capsid, and two in E2 (Table
4). None of these changes has been linked
to laboratory attenuation of the TC-83 vaccine strain (12)
or to other laboratory-generated, attenuated mutants (3).
The changes in nsP1 included (i) a change from asparagine to aspartic
acid at position 167, a region of the protein near the N terminus where
mutations have been shown to affect the methyltransferase and
guanyltransferase activities required for alphavirus RNA genome capping
(17, 18, 26), and (ii) a change from leucine to
phenylalanine at position 528, closer to a region known to affect
minus-strand RNA synthesis (7, 25). The
histidine-to-tyrosine change at position 212 of nsP3 lies within the
N-terminal conserved domain believed to be required for viral RNA
synthesis (7, 29), while the threonine-to-methionine change
at position 360 is in the poorly conserved C-terminal region thought to
be heavily phosphorylated in some alphaviruses (15, 20). The
function of this region is unknown. The glycine-to-arginine change at
capsid position 76 lies within the N-terminal domain that is highly
positively charged, poorly conserved, and believed to interact
electrostatically with the RNA genome (29). Both E2 envelope
glycoprotein amino acid changes (Table 4) lie within or
near an important span of amino acids at positions 182 through 207 shown previously to react with monoclonal antibodies that neutralize
viral infectivity, block hemagglutination, and passively protect mice
(8). Because the VEE virus sequences we determined were
extremely closely related, the probability of actual, historical mutations being omitted in the terminal tree branches due to a failure
to detect superimposed substitutions of the same nucleotide position is
very low; both the Jukes-Cantor (10) and Kimura two-parameter (11) formulas for genetic distance correction estimated that less than 1% of substitutions were obscured in the
direct sequence comparisons used for the maximum-parsimony analysis.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 2.
Maximum-parsimony phylogenetic tree, derived from
complete nonstructural and structural polyprotein amino acid
sequences, showing relationships among VEE virus strains. Branches are
labeled to reflect predicted ancestral epidemiological phenotypes
(enzootic or epizootic) obtained by minimizing changes in the
tree. Numbers represent amino acid changes in terminal branches
representing epizootic virus emergence. Diagonal lines show two
pairs of amino acid changes shared by two epizootic emergence
events. Bootstrap values were 100% for all nodes in the tree of
identical topology obtained by nucleotide sequence analysis.
|
|
To identify evidence of genetic changes common to two or more of the
three VEE virus emergence events, which might represent
epizootic determinants under selection by equine or mosquito
hosts
resulting in convergent evolution, we compared the nucleotide
and
amino acid changes in the three branches representing the
phenotypic
transition from enzootic to epizootic (Fig.
2). The
threonine-to-methionine change at nsP3 position 360 was predicted
to
have accompanied the independent evolution of both IC lineages,
and the
glutamic acid-to-valine change at nsP2 position 340 accompanied
the
emergences of both the 1963 IC genotype and the IAB
viruses.
Plaque size phenotypes.
Previous studies by Martin et al.
(16) revealed a strong correlation between plaque size on
Vero cells and the epidemiological phenotype and equine virulence of
VEE virus strains. All 87 epizootic viruses examined had mean
plaque diameters of ca. 1 to 2 mm, while 61 enzootic strains had plaque
diameters ranging from 2 to 4 mm. To determine if this phenotypic
correlation is maintained for the more closely related enzootic and
epizootic isolates that we have identified, we determined
plaque sizes for three of the ID strains (66647, 66637, and ZPC738) and
the two IC strains (SH3 and 243937) that we sequenced. The enzootic ID
strains all grew to mean plaque diameters of about 4 mm, whereas the
two epizootic IC strains produced plaques of about 2 mm (Table
5) (P < 0.01; Student's
t test). To determine if these enzootic and
epizootic strains were phenotypically similar to others
examined previously (16), we also determined sizes for the
epizootic strains Trinidad donkey and P676, as well as the
enzootic strains 3880 and Fe-37c (Everglades virus, subtype II). These
strains showed approximately the same plaque sizes as reported
previously (16), and no significant differences were
observed when the less recently isolated epizootic strains
Trinidad donkey and P676 were compared with SH3 and 243937 or when 3880 and Fe-37c were compared with strains 66457, 66637, and ZPC738 (Table
5) (P > 0.3; Student's t test). These
results support the previous conclusion of Martin et al.
(16) that plaque size on Vero cells is a useful indicator of
the epidemiological phenotype of VEE viruses. However, the
epidemiological potential, rather than just the history of these
viruses, needs to be confirmed before this marker can be fully
evaluated.
 |
DISCUSSION |
Although VEE virus has caused numerous equine epizootics
and epidemics in the Americas in this century, the source of the epidemics and epizootics, variety IAB and IC viruses, and their mechanism of interepizootic persistence were unknown.
Phylogenetic analyses indicated that epidemic/epizootic
viruses probably arose several times from variety ID-like
ancestors in northern South America (21, 37). The results
presented here provide further evidence in support of this conclusion.
Genomic sequences of enzootic subtype ID strains from western
Venezuela and eastern Colombia showed a very close genetic relationship
to epizootic subtype IC strains isolated from a 1992-1993
Venezuelan outbreak. The enzootic ID strains most closely related to
epizootic IC viruses, based on partial PE2 sequences
(21), were 66637 and 66457 from Zulia State near the Guajira
Peninsula; these enzootic strains differed from the 1992-1993 IC
isolates by a nucleotide divergence of only 1.4% in the PE2 region. In
this paper, we report that the entire genomes of these viruses differ
from that of the IC strains by only 0.8 to 0.9% at the nucleotide
level. Strain ZPC738, isolated in 1997 from the Catatumbo region of
southern Zulia State, is even more closely related to epizootic
viruses and differs from these IC viruses by only 0.7%. The close
proximity of the Catatumbo region to the epicenter of the 1992-1993
outbreak near Trujillo provides a stronger epidemiological link between
enzootic virus circulation and epizootic emergence and suggests
the possibility of future VEE virus emergences in western Venezuela.
The extremely close genetic relationship among these enzootic and
epizootic VEE virus strains supports a hypothetical model for the genetic mechanisms of epizootic VEE virus
emergence. The enzootic ID viruses from Venezuela are presumed to be
equine avirulent, based on previous experimental studies with other
subtype ID viruses (32). In addition, the natural
history of VEE in western Venezuela suggests that these enzootic VEE
viruses are not virulent for horses; unvaccinated equines reside
directly adjacent to the forests where enzootic ID viruses circulate in
the Catatumbo region, yet there is no history of equine encephalitis in
this region. Natural vaccination by avirulent enzootic viruses is a
hypothetical explanation for this observation. However, the avirulent
nature of these Venezuelan enzootic ID viruses and lack of preexisting
epizootic potential must ultimately be confirmed with
experimental equine infections.
Our hypothetical model for VEE virus emergence involves the mutation of
enzootic subtype ID viruses, resulting in enhanced equine viremia and
disease, and selection of the virulent, epizootic phenotypes in
equines and possibly epizootic mosquito vectors (34). High-titered equine viremia, a critical factor
allowing efficient transmission by various epizootic mosquito
vectors with only moderate oral susceptibility, is hypothetically
caused by one or a few of the mutations we have predicted to have
accompanied the 1992 emergence (Table 4). A likely candidate is the
change at position 360 in nsP3 from threonine to methionine, a mutation predicted by phylogenetic analysis to also have accompanied the independent emergence of a different subtype IC lineage in the early
1960s (Fig. 2). Other likely candidates are the amino acid changes
encoded by the nsP1, nsP3, capsid, and E2 genes (Table 4). The
correlation between VEE virus serotype and the epizootic phenotype suggests that the E2 gene, the site of the major VEE virus
antigenic determinants, including hemagglutination inhibition (8,
24), is also involved in epizootic emergence. However, the lack of any E2 mutations common to the three VEE virus emergence events delineated in our phylogenetic analysis (Fig. 2) indicates that
different E2 mutations can probably generate the same IC serotype. The
occurrence of two E2 mutations involving charge alterations on the
surface of the E2 protein implies that these could affect the binding
of the virus to cells and thus influence pathogenesis. These hypotheses
need to be tested with congeneic mutants generated from infectious
clones that we are now developing.
Elucidation of the minimum number of mutations required to generate the
epizootic phenotype will be important in predicting the
frequency at which future outbreaks will occur and the constraints on
epizootic activity. If only a small number of mutations is required, the high mutation rate of RNA viruses like VEE virus would
result in the frequent generation of viruses with
epizootic potential. Assuming a mutation frequency of about
10
4 (estimated previously for another alphavirus,
eastern equine encephalitis [35]), a VEE double
mutant should occur in most naturally infected rodents, which develop
viremia of up to 108 PFU/ml after experimental infection
with enzootic subtype ID viruses (39). Triple
mutants would be expected to occur approximately once in
every 1,000 to 10,000 infected hosts. Rates of epizootic mutant generation in enzootic Culex
(Melanoconion) mosquito vectors should be lower because
viral populations in mosquitoes rarely exceed about 107 PFU
(27). If only a relatively small number of mutations (i.e., two to three) is required for generation of the equine-virulent phenotype, ecological requirements for epizootic
transmission may limit the frequency of outbreaks. Ecological
requirements may include the availability of susceptible equines for
local virus amplification or the transport of an infected equine
harboring a mutant epizootic virus to another region with
susceptible populations. The limited seasonal availability of
large populations of mammalophilic mosquitoes may also limit the
amplification of epizootic mutants.
A more complete understanding of VEE virus emergence and elucidation of
the mutations needed to generate equine-virulent, epizootic
virus strains from enzootic progenitors will require the use of
infectious cDNA clones generated from the strains we have implicated in
the 1992 emergence event, followed by mutagenesis and experimental
equine infections for phenotypic characterization. These studies are
now underway in our laboratory.
 |
ACKNOWLEDGMENTS |
We thank Carmen Zulay Garcia, Exeario Marquez, Yovani Marquez,
Rafael Paz, Osmel Paz, Vidal Paz, and William Sweeney for excellent technical assistance and Charles Fulhorst and Abelardo Moncayo for help
with data analysis. Pedro Morell provided critical logistical help.
Charles Calisher, Robert Shope, and Robert Tesh provided some of the
VEE virus strains that we studied.
This research was supported by National Institutes of Health grant
AI39800 and the National Aeronautics and Space Administration.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department
of Pathology, University of Texas Medical Branch, Galveston, TX
77555-0609. Phone: (409) 747-0758. Fax: (409) 747-2415. E-mail:
sweaver{at}utmb.edu.
 |
REFERENCES |
| 1.
|
Beck, C. E., and R. W. G. Wyckoff.
1938.
Venezuelan equine encephalomyelitis.
Science
88:530[Free Full Text].
|
| 2.
|
Cilnis, M. J.,
W. Kang, and S. C. Weaver.
1996.
Genetic conservation of Highlands J viruses.
Virology
218:343-351[Medline].
|
| 3.
|
Davis, N. L.,
P. Powell,
G. F. Greenwald,
L. V. Willis,
B. J. B. Johnson,
J. F. Smith, and R. E. Johnston.
1991.
Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length clone.
Virology
183:20-31[Medline].
|
| 4.
|
Devereux, J.,
P. Haeberli, and O. Smithies.
1984.
A comprehensive set of sequence analysis programs for the VAX.
Nucleic Acids Res.
12:387-395.
|
| 5.
|
Dickerman, R. W.,
E. W. Cupp,
H. Groot,
A. M. Alarcon,
E. Cura,
A. W. Dickerman,
A. L. Ibagos,
R. Rico-Hesse,
C. A. Taylor, and S. C. Weaver.
1986.
Venezuelan equine encephalomyelitis virus activity in northern Colombia during April and May 1983.
PAHO Bull.
20:276-283.
|
| 6.
|
Felsenstein, J.
1985.
Confidence limits on phylogenies: an approach using the bootstrap.
Evolution
39:783-791.
|
| 7.
|
Hahn, Y. S.,
E. G. Strauss, and J. H. Strauss.
1989.
Mapping of RNA temperature-sensitive mutants of Sindbis virus: assignment of complementation groups A, B, and G to nonstructural proteins.
J. Virol.
63:3142-3150[Abstract/Free Full Text].
|
| 8.
|
Johnson, B. J.,
J. R. Brubaker,
J. T. Roehrig, and D. W. Trent.
1990.
Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein.
Virology
177:676-683[Medline].
|
| 9.
|
Johnston, R. E., and C. J. Peters.
1996.
Alphaviruses, p. 843-898.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa.
|
| 10.
|
Jukes, T. H., and C. R. Cantor.
1969.
Evolution of protein molecules, p. 21-132.
In
H. N. Munro (ed.), Mammalian protein metabolism. Academic Press, New York, N.Y.
|
| 11.
|
Kimura, M.
1980.
A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences.
J. Mol. Evol.
16:111-120[Medline].
|
| 12.
|
Kinney, R. M.,
G.-J. Chang,
K. R. Tsuchiya,
J. M. Sneider,
J. T. Roehrig,
T. M. Woodward, and D. W. Trent.
1993.
Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein.
J. Virol.
67:1269-1277[Abstract/Free Full Text].
|
| 13.
|
Kinney, R. M.,
K. R. Tsuchiya,
J. M. Sneider, and D. W. Trent.
1992.
Molecular evidence for the origin of the widespread Venezuelan equine encephalitis epizootic of 1969-1972.
J. Gen. Virol.
73:3301-3305[Abstract/Free Full Text].
|
| 14.
|
Kubes, V., and F. A. Rios.
1939.
The causative agent of infectious equine encephalomyelitis in Venezuela.
Science
90:20-21[Free Full Text].
|
| 15.
|
Li, G. P.,
M. W. La Starza,
W. R. Hardy,
J. H. Strauss, and C. M. Rice.
1990.
Phosphorylation of Sindbis virus nsP3 in vivo and in vitro.
Virology
179:416-427[Medline].
|
| 16.
|
Martin, D. H.,
W. H. Dietz,
O. Alvaerez, Jr., and K. M. Johnson.
1982.
Epidemiological significance of Venezuelan equine encephalomyelitis virus in vitro markers.
Am. J. Trop. Med. Hyg.
31:561-568.
|
| 17.
|
Mi, S.,
R. Durbin,
H. V. Huang,
C. M. Rice, and V. Stollar.
1989.
Association of the Sindbis virus RNA methyltransferase activity with the nonstructural protein nsP1.
Virology
170:385-391[Medline].
|
| 18.
|
Mi, S., and V. Stollar.
1990.
Both amino acid changes in nsP1 of Sindbis virus LM21 contribute to and are required for efficient expression of the mutant phenotype.
Virology
178:429-434[Medline].
|
| 19.
|
Oberste, M. S.,
M. D. Parker, and J. F. Smith.
1996.
Complete sequence of Venezuelan equine encephalitis virus subtype IE reveals conserved and hypervariable domains within the C terminus of nsP3.
Virology
219:314-320[Medline].
|
| 20.
|
Peranen, J.,
K. Takkinen,
N. Kalkkinen, and L. Kaariainen.
1988.
Semliki Forest virus-specific non-structural protein nsP3 is a phosphoprotein.
J. Gen. Virol.
69:2165-2178[Abstract/Free Full Text].
|
| 21.
|
Powers, A. M.,
M. S. Oberste,
A. C. Brault,
R. Rico-Hesse,
S. M. Schmura,
J. F. Smith,
W. Kang,
W. P. Sweeney, and S. C. Weaver.
1997.
Repeated emergence of epidemic/epizootic Venezuelan equine encephalitis from a single genotype of enzootic subtype ID virus.
J. Virol.
71:6697-6705[Abstract].
|
| 22.
|
Rico-Hesse, R.,
S. C. Weaver,
J. de Siger,
G. Medina, and R. A. Salas.
1995.
Emergence of a new epidemic/epizootic Venezuelan equine encephalitis virus in South America.
Proc. Natl. Acad. Sci. USA
92:5278-5281[Abstract/Free Full Text].
|
| 23.
|
Roehrig, J. T., and R. A. Bolin.
1997.
Monoclonal antibodies capable of distinguishing epizootic from enzootic varieties of subtype 1 Venezuelan equine encephalitis viruses in a rapid indirect immunofluorescence assay.
J. Clin. Microbiol.
35:1887-1890[Abstract].
|
| 24.
|
Roehrig, J. T., and J. H. Mathews.
1985.
The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes.
Virology
142:347-356[Medline].
|
| 25.
|
Sawicki, D. L.,
S. G. Sawicki,
S. Keränen, and L. Kääriäinen.
1981.
Specific Sindbis virus-coded function for minus-strand RNA synthesis.
J. Virol.
39:348-358[Abstract/Free Full Text].
|
| 26.
|
Scheidel, L. M.,
R. K. Durbin, and V. Stollar.
1987.
Sindbis virus mutants resistant to mycophenolic acid and ribavirin.
Virology
158:1-7[Medline].
|
| 27.
|
Scherer, W. F.,
E. W. Cupp,
J. B. Lok,
R. J. Brenner, and J. V. Ordonez.
1981.
Intestinal threshold of an enzootic strain of Venezuelan equine encephalomyelitis virus in Culex (Melanoconion) taeniopus mosquitoes and its implication to vector competency and vertebrate amplifying hosts.
Am. J. Trop. Med. Hyg.
30:862-869.
|
| 28.
|
Schlesinger, S., and M. J. Schlesinger.
1996.
Togaviridae: the viruses and their replication, p. 825-842.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa.
|
| 29.
|
Strauss, J. H., and E. G. Strauss.
1994.
The alphaviruses: gene expression, replication, and evolution.
Microbiol. Rev.
58:491-562[Abstract/Free Full Text].
|
| 30.
|
Swofford, D. L.
1991.
PAUP: phylogenetic analysis using parsimony, version 3.0.
Illinois Natural History Survey, Champaign.
|
| 31.
|
Walder, R.,
O. M. Suarez, and C. H. Calisher.
1984.
Arbovirus studies in the Guajira region of Venezuela: activities of eastern equine encephalitis and Venezuelan equine encephalitis viruses during an interepizootic period.
Am. J. Trop. Med. Hyg.
33:699-707.
|
| 32.
|
Walton, T. E.,
O. Alvarez,
R. M. Buckwalter, and K. M. Johnson.
1973.
Experimental infection of horses with enzootic and epizootic strains of Venezuelan equine encephalomyelitis virus.
J. Infect. Dis.
128:271-282[Medline].
|
| 33.
|
Walton, T. E., and M. A. Grayson.
1988.
Venezuelan equine encephalomyelitis, p. 203-233.
In
T. P. Monath (ed.), The arboviruses: epidemiology and ecology, vol. IV. CRC Press, Boca Raton, Fla.
|
| 34.
|
Weaver, S. C.
1998.
Recurrent emergence of Venezuelan equine encephalomyelitis, p. 27-42.
In
W. M. Scheld, D. Armstrong, and J. M. Hughes (ed.), Emerging infections 1. ASM Press, Washington, D.C.
|
| 35.
|
Weaver, S. C.,
L. A. Bellew,
L. A. Gousset,
P. A. Repik,
T. W. Scott, and J. J. Holland.
1993.
Diversity within natural populations of eastern equine encephalomyelitis virus.
Virology
195:700-709[Medline].
|
| 36.
|
Weaver, S. C.,
A. Hagenbaugh,
L. A. Bellew,
L. Gousset,
V. Mallampalli,
J. J. Holland, and T. W. Scott.
1994.
Evolution of alphaviruses in the eastern equine encephalomyelitis complex.
J. Virol.
68:158-169[Abstract/Free Full Text].
|
| 37.
|
Weaver, S. C.,
L. A. Bellew, and R. Rico-Hesse.
1992.
Phylogenetic analysis of alphaviruses in the Venezuelan equine encephalitis complex and identification of the source of epizootic viruses.
Virology
191:282-290[Medline].
|
| 38.
|
Weaver, S. C.,
R. Salas,
R. Rico-Hesse,
G. V. Ludwig,
M. S. Oberste,
J. Boshell, and R. B. Tesh.
1996.
Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America.
Lancet
348:436-440[Medline].
|
| 39.
|
Young, N. A.,
K. M. Johnson, and L. W. Gauld.
1969.
Viruses of the Venezuelan equine encephalomyelitis complex. Experimental infection of Panamanian rodents.
Am. J. Trop. Med. Hyg.
18:290-296.
|
Journal of Virology, May 1999, p. 4266-4271, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
NI, H., YUN, N. E., ZACKS, M. A., WEAVER, S. C., TESH, R. B., DA ROSA, A. P. T., POWERS, A. M., FROLOV, I., PAESSLER, S.
(2007). RECOMBINANT ALPHAVIRUSES ARE SAFE AND USEFUL SEROLOGICAL DIAGNOSTIC TOOLS. Am J Trop Med Hyg
76: 774-781
[Abstract]
[Full Text]
-
Wang, E., Paessler, S., Aguilar, P. V., Carrara, A.-S., Ni, H., Greene, I. P., Weaver, S. C.
(2006). Reverse Transcription-PCR-Enzyme-Linked Immunosorbent Assay for Rapid Detection and Differentiation of Alphavirus Infections. J. Clin. Microbiol.
44: 4000-4008
[Abstract]
[Full Text]
-
Anishchenko, M., Bowen, R. A., Paessler, S., Austgen, L., Greene, I. P., Weaver, S. C.
(2006). From the Cover: Venezuelan encephalitis emergence mediated by a phylogenetically predicted viral mutation. Proc. Natl. Acad. Sci. USA
103: 4994-4999
[Abstract]
[Full Text]
-
Greene, I. P., Paessler, S., Austgen, L., Anishchenko, M., Brault, A. C., Bowen, R. A., Weaver, S. C.
(2005). Envelope Glycoprotein Mutations Mediate Equine Amplification and Virulence of Epizootic Venezuelan Equine Encephalitis Virus. J. Virol.
79: 9128-9133
[Abstract]
[Full Text]
-
GREENE, I. P., PAESSLER, S., ANISHCHENKO, M., SMITH, D. R., BRAULT, A. C., FROLOV, I., WEAVER, S. C.
(2005). VENEZUELAN EQUINE ENCEPHALITIS VIRUS IN THE GUINEA PIG MODEL: EVIDENCE FOR EPIZOOTIC VIRULENCE DETERMINANTS OUTSIDE THE E2 ENVELOPE GLYCOPROTEIN GENE. Am J Trop Med Hyg
72: 330-338
[Abstract]
[Full Text]
-
Brault, A. C., Powers, A. M., Ortiz, D., Estrada-Franco, J. G., Navarro-Lopez, R., Weaver, S. C.
(2004). Venezuelan equine encephalitis emergence: Enhanced vector infection from a single amino acid substitution in the envelope glycoprotein. Proc. Natl. Acad. Sci. USA
101: 11344-11349
[Abstract]
[Full Text]
-
Anishchenko, M., Paessler, S., Greene, I. P., Aguilar, P. V., Carrara, A.-S., Weaver, S. C.
(2004). Generation and Characterization of Closely Related Epizootic and Enzootic Infectious cDNA Clones for Studying Interferon Sensitivity and Emergence Mechanisms of Venezuelan Equine Encephalitis Virus. J. Virol.
78: 1-8
[Abstract]
[Full Text]
-
SAHU, S. P., PEDERSEN, D. D., JENNY, A. L., SCHMITT, B. J., ALSTAD, A. D.
(2003). PATHOGENICITY OF A VENEZUELAN EQUINE ENCEPHALOMYELITIS SEROTYPE IE VIRUS ISOLATE FOR PONIES. Am J Trop Med Hyg
68: 485-494
[Abstract]
[Full Text]
-
Wang, E., Brault, A. C., Powers, A. M., Kang, W., Weaver, S. C.
(2002). Glycosaminoglycan Binding Properties of Natural Venezuelan Equine Encephalitis Virus Isolates. J. Virol.
77: 1204-1210
[Abstract]
[Full Text]
-
Brault, A. C., Powers, A. M., Weaver, S. C.
(2002). Vector Infection Determinants of Venezuelan Equine Encephalitis Virus Reside within the E2 Envelope Glycoprotein. J. Virol.
76: 6387-6392
[Abstract]
[Full Text]
-
Brault, A. C., Powers, A. M., Holmes, E. C., Woelk, C. H., Weaver, S. C.
(2002). Positively Charged Amino Acid Substitutions in the E2 Envelope Glycoprotein Are Associated with the Emergence of Venezuelan Equine Encephalitis Virus. J. Virol.
76: 1718-1730
[Abstract]
[Full Text]
-
Powers, A. M., Brault, A. C., Shirako, Y., Strauss, E. G., Kang, W., Strauss, J. H., Weaver, S. C.
(2001). Evolutionary Relationships and Systematics of the Alphaviruses. J. Virol.
75: 10118-10131
[Abstract]
[Full Text]
-
Brault, A. C., Powers, A. M., Medina, G., Wang, E., Kang, W., Salas, R. A., De Siger, J., Weaver, S. C.
(2001). Potential Sources of the 1995 Venezuelan Equine Encephalitis Subtype IC Epidemic. J. Virol.
75: 5823-5832
[Abstract]
[Full Text]
-
White, L. J., Wang, J.-G., Davis, N. L., Johnston, R. E.
(2001). Role of Alpha/Beta Interferon in Venezuelan Equine Encephalitis Virus Pathogenesis: Effect of an Attenuating Mutation in the 5' Untranslated Region. J. Virol.
75: 3706-3718
[Abstract]
[Full Text]